The role of granulocyte transfusions in neutropenic patients

British Journal of Haematology

Volumn 127, Issue 5, 2004, Pages 501-508

  Bishton, M ^a   Chopra, R ^b,c  

^a NOTTINGHAM CITY HOSPITAL   (United Kingdom)

^b Astrazenca ^*  (United Kingdom)

^c ASTRAZENECA   (United Kingdom)

Author keywords

Granulocyte; Granulocyte colony stimulating factor; Neutropenia; Transfusions

Indexed keywords

ANTICOAGULANT AGENT; CITRIC ACID; CORTICOSTEROID; DEXAMETHASONE; GRANULOCYTE COLONY STIMULATING FACTOR; HETASTARCH; PREDNISOLONE;

BONE PAIN; CATARACT; CONTROLLED STUDY; CORTICOSTEROID THERAPY; CYTOMEGALOVIRUS INFECTION; FATIGUE; FLUSHING; GRAFT VERSUS HOST REACTION; GRANULOCYTE TRANSFUSION; HEADACHE; HUMAN; HYPERTENSION; HYPOVOLEMIA; IMMUNOPHENOTYPING; INSOMNIA; LEUKAPHERESIS; MAJOR CLINICAL STUDY; MYALGIA; NEUTROPENIA; PARESTHESIA; PRIORITY JOURNAL; REVIEW; SEPSIS; SIDE EFFECT; TREATMENT INDICATION; TREATMENT OUTCOME;

BACTERIAL INFECTIONS; GRANULOCYTE COLONY-STIMULATING FACTOR; GRANULOCYTES; HUMANS; IMMUNOCOMPROMISED HOST; LEUKOCYTE TRANSFUSION; NEUTROPENIA;

EID: 10344232635     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2004.05221.x     Document Type: Review

References (62)

1. Adkins, D., Goodgold, H., Hendershott, L., Johnston, M., Cravens, D. & Spitzer, G. (1997) Indium-labeled white blood cells apheresed from donors receiving G-CSF localize to sites of inflammation when infused into allogeneic bone marrow transplant recipients. Bone Marrow Transplantation, 19, 809-812.
2. Adkins, D., Goodnough, L.T., Moellering, J., Brown, R., Khoury, H., Vij, R. & DiPersio, J. (1999) Reduction in antibiotic utilization and in febrile days by transfusion of G-CSF mobilized prophylactic granulocyte components: a randomized study. Blood, 94, 590a (abstract).
3. Alavi, J.B., Root, R.K., Djerassi, I., Evans, A.E., Gluckman, S.J., MacGregor, R.R., Guerry, D., Schreiber, A.D., Shaw, J.M., Koch, P. & Cooper, R.A. (1977) A randomized clinical trial of granulocyte transfusions for infection in acute leukemia. New England Journal of Medicine, 296, 706-711.
4. Anderlini, P., Przepiorka, D., Seong, D., Miller, P., Sundberg, J., Lichtiger, B., Norfleet, F., Chan, K.W., Champlin, R. & Korbling, M. (1996) Clinical toxicity and laboratory effects of granulocyte-colony-stimulating factor (filgrastim) mobilization and blood stem cell apheresis from normal donors, and analysis of charges for the procedures. Transfusion, 36, 590-595.
5. Appelbaum, F.R., Bowles, C.A., Makuch, R.W. & Deisseroth, A.B. (1978) Granulocyte transfusion therapy of experimental Pseudomonas septicemia: study of cell dose and collection technique. Blood, 52, 323-331.
6. Berliner, S., Weinberger, M., Ben-Bassat, M., Lavie, G., Weinberger, A., Giller, S. & Pinkhas, J. (1985) Amphotericin B causes aggregation of neutrophils and enhances pulmonary leukostasis. American Review of Respiratory Disease, 132, 602-605.
7. BitMansour, A., Burns, S.M., Traver, D., Akashi, K., Contag, C.H., Weissman, I.L. & Brown, J.M. (2002) Myeloid progenitors protect against invasive aspergillosis and Pseudomonas aeruginosa infection following hematopoietic stem cell transplantation. Blood, 100, 4660-4667.
8. Blum, W., Hallem, C., Vij, R. & Adkins, R. (2001) Improved survival in allogeneic peripheral blood stem cell (PBSC) transplant patients who received prophylactic granulocyte transfusions from HLA matched donors: long term follow up. Blood, 98, 58a.
9. Bodey, G.P., Buckley, M., Sathe, Y.S. & Freireich, E.J. (1966) Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia. Annals of Internal Medicine, 64, 328-340.
10. Bodey, G., Bueltmann, B., Duguid, W., Gibbs, D., Hanak, H., Hotchi, M., Mall, G., Martino, P., Meunier, F. & Milliken, S. (1992) Fungal infections in cancer patients: an international autopsy survey. European Journal of Clinical Microbiology and Infectious Diseases, 11, 99-109.
11. Brecher, G., Wilbur, K.M. & Cronkite, E.P. (1953) Transfusion of separated leukocytes into irradiated dogs with aplastic marrows. Proceedings of the Society for Experimental Biology and Medicine, 84, 54-56.
12. Cavallaro, A.M., Lilleby, K., Majolino, I., Storb, R., Appelbaum, F.R., Rowley, S.D. & Bensinger, W.I. (2000) Three to six year follow-up of normal donors who received recombinant human granulocyte colony-stimulating factor. Bone Marrow Transplantation, 25, 85-89.
13. Cesaro, S., Chinello, P., De Silvestro, G., Marson, P., Picco, G., Varotto, S., Pittalis, S. & Zanesco, L. (2003) Granulocyte transfusions from G-CSF-stimulated donors for the treatment of severe infections in neutropenic pediatric patients with onco-hematological diseases. Supportive Care in Cancer, 11, 101-106.
14. Chopra, R. (2002) AmBisome in the treatment of fungal infections: the UK experience. Journal of Antimicrobial Chemotherapy, 49 (Suppl. 1), 43-47.
15. Clift, R.A., Sanders, J.E., Thomas, E.D., Williams, B. & Buckner, C.D. (1978) Granulocyte transfusions for the prevention of infection in patients receiving bone-marrow transplants. New England Journal of Medicine, 298, 1052-1057.
16. Dutcher, J.P., Kendall, J., Norris, D., Schiffer, C., Aisner, J. & Wiernik, P.H. (1989) Granulocyte transfusion therapy and amphotericin B: adverse reactions? American Journal of Hematology, 31, 102-108.
17. Fanconi, S., Seger, R., Gmur, J., Willi, U., Schaer, G., Spiess, H., Otto, R. & Hitzig, W.H. (1985) Surgery and granulocyte transfusions for life-threatening infections in chronic granulomatous disease. Helvetica Paediatrica Acta, 40, 277-284.
18. Fortuny, I.E., Bloomfield, C.D., Hadlock, D.C., Goldman, A., Kennedy, B.J. & McCullough, J.J. (1975) Granylocyte transfusion: a controlled study in patients with acuute nonlymphocytic leukemia. Transfusion, 15, 548-558.
19. Freireich, E.J., Judson, G. & Levin, R.H. (1965) Separation and collection of leukocytes. Cancer Research, 25, 1516-1520.
20. Ghodsi, Z. & Strauss, R.G. (2001) Cataracts in neutrophil donors stimulated with adrenal corticosteroids. Transfusion, 41, 1464-1468.
21. Graw, Jr, R.G., Herzig, G., Perry, S. & Henderson, E.S. (1972) Normal granulocyte transfusion therapy: treatment of septicemia due to gram-negative bacteria. New England Journal of Medicine, 287, 367-371.
22. Grigg, A., Vecchi, L., Bardy, P. & Szer, J. (1996) G-CSF stimulated donor granulocyte collections for prophylaxis and therapy of neutropenic sepsis. Australian and New Zealand Journal of Medicine, 26, 813-818.
23. Grigull, L., Schrauder, A., Schmitt-Thomssen, A., Sykora, K. & Welte, K. (2002) Efficacy and safety of G-CSF mobilized granulocyte transfusions in four neutropenic children with sepsis and invasive fungal infection. Infection, 30, 267-271.
24. Haidenberger, A., Hengster, P., Kunc, M., Micke, O., Wolfgruber, T., Auer, T., Lukas, P. & DeVries, A. (2003) Influence of fractionated irradiation on neutrophilic granulocyte function. Strahlentherapie und Onkologie, 179, 45-49.
25. Hassan, I.A., Chopra, R., Swindell, R. & Mutton, K.J. (2003) Respiratory viral infections after bone marrow/peripheral stem-cell transplantation: the Christie hospital experience. Bone Marrow Transplantation, 32, 73-77.
26. Herbrecht, R., Denning, D.W., Patterson, T.F., Bennett, J.E., Greene, R.E., Oestmann, J.W., Kern, W.V., Marr, K.A., Ribaud, P., Lortholary, O., Sylvester, R., Rubin, R.H., Wingard, J.R., Stark, P., Durand, C, Caillot, D., Thiel, E., Chandrasekar, P.H., Hodges, M.R., Schlamm, H.T., Troke, P.F. & de Pauw, B. (2002) Invasive Fungal Infections Group of the European Organisation for Research and Treatment of Cancer and the Global Aspergillus Study Group. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. New England Journal of Medicine, 347, 408-415.
27. Herzig, R.H., Herzig, G.P., Graw, Jr, R.G., Bull, M.I. & Ray, K.K. (1977) Successful granulocyte transfusion therapy for gram-negative septicemia. A prospectively randomized controlled study. New England Journal of Medicine, 296, 701-705.
28. Hester, J.P., Dignani, M.C., Anaissie, E.J., Kantarjian, H.M., O'Brien, S. & Freireich, E.J. (1995) Collection and transfusion of granulocyte concentrates from donors primed with granulocyte stimulating factor and response of myelosuppressed patients with established infection. Journal of Clinical Apheresis, 10, 188-193.
29. Higby, D.J., Yates, J.W., Henderson, E.S. & Holland, J.F. (1975) Filtration leukapheresis for granulocyte transfusion therapy. Clinical and laboratory studies. New England Journal of Medicine, 292, 761-766.
30. Hubel, K., Dale, D.C., Rodger, E., Gaviria, J.M., Price, T.H. & Liles, W.C. (2000) Preservation of function in granulocyte concentrates collected from donors stimulated with G-CSF/dexamethasone during storage at reduced temperature. Blood, 96, 820a.
31. Hubel, K., Carter, R.A., Liles, W.C., Dale, D.C., Price, T.H., Bowden, R.A., Rowley, S.D., Chauncey, T.R., Bensinger, W.I. & Boeckh, M. (2002) Granulocyte transfusion therapy for infections in candidates and recipients of HPC transplantation: a comparative analysis of feasibility and outcome for community donors versus related donors. Transfusion, 42, 1414-1421.
32. Hughes, W.T., Armstrong, D., Bodey, G.P., Brown, A.E., Edwards, J.E., Feld, R., Pizzo, P., Rolston, K.V., Shenep, J.L. & Young, L.S. (1997) 1997 guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever. Infectious Diseases Society of America. Clinical Infectious Diseases, 25, 551-573.
33. Hughes, W.T., Armstrong, D., Bodey, G.P., Bow, E.J., Brown, A.E., Calandra, T., Feld, R., Pizzo, P.A., Rolston, K.V., Shenep, J.L. & Young, L.S. (2002) 2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer. Clinical Infectious Diseases, 15, 730-751.
34. Karp, D.D., Ervin, T.J., Tuttle, S., Gorgone, B.C., Lavin, P. & Yunis, E.J. (1982) Pulmonary complications during granulocyte transfusions: incidence and clinical features. Vox Sanguinis, 42, 57-61.
35. Kerr, J.P., Liakopolou, E., Brown, J., Cornish, J.M., Fleming, D., Massey, E., Oakhill, A., Pamphilon, D.H., Robinson, S.P., Totem, A., Valencia, A.M. & Marks, D.I. (2003) The use of stimulated granulocyte transfusions to prevent recurrence of past severe infections after allogeneic stem cell transplantation. British Journal of Haematology, 123, 114.
36. Lee, J.J., Chung, I.J., Park, M.R., Kook, H., Hwang, T.J., Ryang, D.W. & Kim, H.J. (2001) Clinical efficacy of granulocyte transfusion therapy in patients with neutropenia-related infections. Leukemia, 15, 203-207.
37. Levin, R.H., Whang, J., Carbone, P.P. & Freireich, E.J. (1965) Erythroid homograft following leukocyte transfusion in a patient with acute leukemia. I. Clinical studies and implications. Blood, 26, 587-596.
38. Liles, W.C., Rodger, E. & Dale, D.C. (2000) Combined administration of G-CSF and dexamethasone for the mobilization of granulocytes in normal donors: optimization of dosing. Transfusion, 40, 642-644.
39. McCullough, J., Clay, M., Hurd, D., Richards, K., Ludvigsen, C. & Forstrom, L. (1986) Effect of leukocyte antibodies and HLA matching on the intravascular recovery, survival, and tissue localization of 111-indium granulocytes. Blood, 67, 522-528.
40. Metchinikoff, E. (1967) Nobel Lectures, Physiology or Medicine, 1901-1921. Elsevier Publishing Company, Amsterdam.
41. Mohan, P. & Brocklehurst, P. (2003) Granulocyte transfusions for neonates with confirmed or suspected sepsis and neutropaenia. Cochrane Database of Systemic Review, 4, CD003956.
42. Nichols, W.G., Price, T. & Boeckh, M. (2003) Donor serostatus and CMV infection and disease among recipients of prophylactic granulocyte transfusions. Blood, 101, 5091-5092.
43. Peters, C., Minkov, M., Matthes-Martin, S., Potschger, U., Witt, V., Mann, G., Hocker, P., Worel, N., Stary, J., Klingebiel, T. & Gadner, H. (1999) Leucocyte transfusions from rhG-CSF or prednisolone stimulated donors for treatment of severe infections in immunocompromised neutropenic patients. British Journal of Haematology, 106, 689-696.
44. Pizzo, P.A. (1993) Management of fever in patients with cancer and treatment-induced neutropenia. New England Journal of Medicine, 328, 1323-1332.
45. von Planta, M., Ozsahin, H., Schroten, H., Stauffer, U.G. & Seger, R.A. (1997) Greater omentum flaps and granulocyte transfusions as combined therapy of liver abscess in chronic granulomatous disease. European Journal of Pediatric Surgery, 7, 234-236.
46. Price, T.H., Bowden, R.A., Boeckh, M., Bux, J., Nelson, K., Liles, W.C. & Dale, D.C. (2000) Phase I/II trial of neutrophil transfusions from donors stimulated with G-CSF and dexamethasone for treatment of patients with infections in hematopoietic stem cell transplantation. Blood, 95, 3302-3309.
47. Siegel, S.E., Lunde, M.N., Gelderman, A.H., Halterman, R.H., Brown, J.A., Levine, A.S. & Graw, R.G. (1971) Transmission of toxoplasmosis by leukocyte transfusion. Blood, 37, 388-394.
48. Singer, M.S., Seibel, N.L., Vezina, G., Choi, S.S. & Dinndorf, P.A. (2003) Successful treatment of invasive aspergillosis in two patients with acute myelogenous leukemia. Journal of Pediatric Hematology/ Oncology, 25, 252-256.
49. Strauss, R.G. (1993) Therapeutic granulocyte transfusions in 1993. Blood, 81, 1675-1678.
50. Stroncek, D.F., Leonard, K., Eiber, G., Malech, H.L., Gallin, J.I. & Leitman, S.F. (1996a) Alloimmunization after granulocyte transfusions. Transfusion, 36, 1009-1015.
51. Stroncek, D.F., Clay, M.E., Petzoldt, M.L., Smith, J., Jaszcz, W., Oldham, F.B. & McCullough, J. (1996b) Treatment of normal individuals with granulocyte-colony-stimulating factor: donor experiences and the effects on peripheral blood CD34 cell counts and on the collection of peripheral blood stem cells. Transfusion, 36, 601-610.
52. Stroncek, D.F., Yau, Y.Y., Oblitas, I. & Leitman, S.F. (2001) Administration of G-CSF plus dexamethasone produces greater granulocyte concentrate yields while causing no more donor toxicity than G-CSF alone. Transfusion, 41, 1037-1044.
53. Strumia, M.M. (1934) The effect of leucocytic cream injections in the treatment of the neutropenias. American Journal of the Medical Sciences, 187, 527-544.
54. Taylor, K.M. (1996) Safety and logistiacl use of filgrastim (FG) mobilised granulocytes (FMG) in early management of severe neutropenic sepsis (SNS) in acute leukaemia (AL)/autograft. Blood, 88, 349a.
55. Vassilev, T.L., Kazatchkine, M.D., Van Huyen, J.P., Mekrache, M., Bonnin, E., Mani, J.C., Lecroubier, C., Korinth, D., Baruch, D., Schriever, F. & Kaveri, S.V. (1999) Inhibition of cell adhesion by antibodies to Arg-Gly-Asp (RGD) in normal immunoglobulin for therapeutic use (intravenous immunoglobulin, IVIg). Blood, 93, 3624-3631.
56. Vij, R., DiPersio, J.F., Venkatraman, P., Trinkaus, K., Goodnough, L.T., Brown, R.A., Khoury, H.J., Devine, S.M., Oza, A., Shenoy, S., Blum, W. & Adkins, D. (2003) Donor CMV serostatus has no impact on CMV viremia or disease when prophylactic granulocyte transfusions are given following allogeneic peripheral blood stem cell transplantation. Blood, 101, 2067-2069.
57. Vogler, W.R. & Winton, E.F. (1977) A controlled study of the efficacy of granulocyte transfusions in patients with neutropenia. American Journal of Medicine, 63, 548-555.
58. Winston, D.J., Ho, W.G., Young, L.S. & Gale, R.P. (1980) Prophylactic granulocyte transfusions during human bone marrow transplantation. American Journal of Medicine, 68, 893-897.
59. Winston, D.J., Ho, W.G. & Gale, R.P. (1982) Therapeutic granulocyte transfusions for documented infections. A controlled trial in ninety-five infectious granulocytopenic episodes. Annals of Internal Medicine, 97, 509-515.
60. Wright, D.G., Robichaud, K.J., Pizzo, P.A. & Deisseroth, A.B. (1981) Lethal pulmonary reactions associated with the combined use of amphotericin B and leukocyte transfusions. New England Journal of Medicine, 304, 1185-1189.
61. Young, L.S. (1981) Fever and Septicaemia. In Management of Infections in Leukemia and Lymphoma in Clinical Approach to Infection in the Compromised Host. (ed. by Rubin, R.H. & Young, L.S.), pp. 461-506. Plenum Medical Book Company, New York.
62. Zarco, M.A., Ribera, J.M., Urbano-Ispizua, A., Filella, X., Arriols, R., Martinez, C., Feliu, E. & Montserrat, E. (1999) Phenotypic changes in neutrophil granulocytes of healthy donors after G-CSF administration. Haematologica, 84, 874-878.